Tibra Equities Europe’s Immunomedics Inc IMMU Stock Holding History

Tibra Equities Europe’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-318,718	Closed	-$27.1M	–	283
2020 Q3	$27.1M	Buy	+318,718	New	+$16.1M	5.71%	4

Tibra Equities Europe's IMMU Position: Q4 2020 in Review

Tibra Equities Europe sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 318,718 shares — an estimated $27.1M sold.

Tibra Equities Europe first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $27.1M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Tibra Equities Europe reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Tibra Equities Europe sold 318,718 Immunomedics Inc shares in Q4 2020, an estimated $27.1M.
Tibra Equities Europe first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Tibra Equities Europe's Immunomedics Inc position peaked at $27.1M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Tibra Equities Europe's 13F filing for Q4 2020, filed 12 Feb 2021.